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President, American“Knowing is not enough; we must apply. Willing is not enough; we must do.”
dJohann Wolfgang von Goethe (1)
n 1999, a report in the New England Journal of Medicine titled “Effect of Race and Sex
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When considered
from the viewpoint
of either the
average American
household or health
care workers, it is
deﬁnitely “our”
problem.Ion Physicians’ Recommendations for Cardiac Catheterization” (2) sent shock wavesthrough the medical community and the lay press. Although the study remains
controversial on both methodological and statistical grounds, its authors concluded that
black women were 60% less likely to receive appropriate cardiac catheterization for angina
than a white male reference group, despite giving the same cardiac and risk-factor histories
to groups of primary care and family practice physicians attending their respective annual
scientiﬁc meetings.
Since that publication, despite a decade of government reports and reforms, initiatives of
medical societies, and focus by researchers and policy makers on the unequal health
outcomes of minorities and women, health disparities have persisted in the United States.
The Facts
Studies continue to demonstrate lower than expected rates of diagnostic testing and poorer
cardiovascular outcomes with treatment of women relative to men. The American College of
Cardiology (ACC) is addressing this issue through continuous efforts speciﬁcally designed
to aide the treatment of heart disease in women. However, recent advances in understanding
differences in pathophysiology and closing treatment gaps in some studies are mitigated by
studies indicating that large commercial plans demonstrate a disparity of 5% in favor of
men for control of risk factors. This is estimated to result in 5,000 to 10,000 excess deaths in
women annually (3).
Cardiovascular diseases, including hypertension, heart disease, and stroke, remain leading
causes of death in the United States. Each of these has higher prevalence, morbidity, and
mortality in African Americans (4). Over the past 40 years, great strides have been made in
cardiovascular diagnosis, therapy, and access to care, resulting in decreased mortality from
these diseases. African Americans, particularly men, in the United States improved the most
over the past decade, with a 22% reduction in mortality (5,6), compared with only an 11%
reduction in white women (Fig. 1). However, this has only slightly narrowed a very wide
gap: the overall life expectancy of white women is 81 years but only 72 years for African
American men.
The Basis
The reasons underlying these dramatic disparities in the incidence, prevalence, and mortality
of cardiovascular diseases have been widely debated. In addition to higher frequencies of
hypertension, diabetes mellitus, cigarette smoking, obesity, and physical inactivity in African
Americans than in whites (4), there are non-disease-related factors that fall into 3 major
categories: genetic differences, individual behaviors (lifestyles), and social (environmental)
Figure 1 United States Age-Adjusted Death Rates per 100,000 Population, Year 2000 Versus 2011 (5,6)
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564issues, revolving mainly around socioeconomic conditions,
cultural factors, delayed presentation for medical care, and
reduced access to high-quality care.
The predominant social issue appears to be a higher
prevalence of poverty, which results in poorer access to
health care and less education. Higher levels of education
and afﬂuence in African Americans have translated to better
understanding of disease processes, closer adherence to
prescribed medical therapy, and lower rates of adverse
behavior (e.g., smoking and fatty food intake) (7). Thus,
when both race and education are considered, the degree of
disparity is even more startling. There is a 14-year difference
in life expectancy between African American men with
fewer than 12 years of education compared with white men
with 16 or more years of education (8).Is it “Their” Problem or “Ours”?
When considered from the viewpoint of either the average
American household or health care workers, it is deﬁnitely
“our” problem.
Large health care disparities, including premature stroke,
myocardial infarction leading to heart failure, and end-stage
renal disease, have always cost society in terms of produc-
tivity. But in 1986, Congress enacted the Emergency
Medical Treatment and Labor Act to ensure public access to
emergency services regardless of ability to pay. This obliges
all Medicare-participating hospitals that offer emergency
services to provide a medical screening examination when
a request is made for examination or treatment for an
emergency medical condition, including active labor,
regardless of a patient’s ability to pay. Hospitals are thenrequired to provide stabilizing treatment for patients with
emergency medical conditions. This was considered by
many as an unfunded mandate. But hospitals increased their
charges to cover the costs of charity care. Thus, the costs of
this legislation are actually passed on to all consumers in the
hospital setting, making it “our” problem.
In addition, when hypertension goes untreated or
undertreated, African Americans develop strokes, congestive
heart failure, and end-stage kidney disease at alarming rates.
Accounting for only 12% of the United States population,
African Americans constitute 33% of the dialysis population
and are immediately fully covered by Medicare, at an esti-
mated $87,561 per patient annually for hemodialysis (9),
fully paid by premiums and tax dollars.
As medical practitioners, we do recognize that physician
biases may play a role in these disparities, as Schulman et al.
(2) described, and we believe that guideline-driven appro-
priate care should reduce the degree of inequality. However,
in the July 2 issue of the Journal, Subherwal et al. (10) re-
ported an analysis of data from the ACC’s PINNACLE
Registry regarding treatment of peripheral artery disease.
They chronicled the self-reported use of “vasculoprotective”
medications, including statins and antiplatelet therapy, in
patients with peripheral artery disease and stratiﬁed the
results on the basis of socioeconomic factors and physician
practice site.
Although it was not surprising that the patients with the
lowest socioeconomic status received less guideline-
recommended medications, it was indeed unexpected to ﬁnd
that the major determinant of the lower prescription of
guideline-recommended medications was physicians’ prac-
tice sites rather than the actual socioeconomic status of
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we face occur because of the education levels of physicians,
who do or do not follow the guidelines in their practices, and
that such physicians tend to work in communities of lower
socioeconomic strata.
Again, this makes it “our” problem.The Way Forward
The ACC has long recognized the contribution of health
care access to these disparities, and we continue to encourage
Congress to adopt payment reforms that would avoid cuts
due to the ﬂawed sustainable growth rate formula that would
worsen access. We will also continue efforts to include
programmatic emphasis about disparities both in online
educational forums and at live programs like the ACC
Annual Scientiﬁc Session, at smaller regional meetings, and
through our state chapters. We will also continue to engage
patients through CardioSmart and through partnerships
with sister societies and community organizations working
to combat this issue as well.
Some recent examples of successful partnerships aimed at
reducing disparities include the ACC’s partnership with the
Association of Black Cardiologists on Spirit of the Heart
community events, as well as the ongoing development of
the Coalition to Reduce Disparities in Cardiovascular
Outcomes (credo). The 3-day Spirit of the Heart events, the
most recent of which occurred as part of ACC.13 in San
Francisco, bring together local community leaders around
the common goal of improving cardiovascular care in
underserved communities, as well as providing free health
screenings to local community groups.
Meanwhile, credo is designed to provide cardiologists,
nurses, and other health care providers who treat or prevent
cardiovascular disease with the tools to ensure optimal care
for their increasingly diverse patients. In a 2011 JACC white
paper, Yancy et al. (11) wrote that “in addition to de novo
educational activities and materials credo.will serve as
a clearinghouse for evidence-based tools and materials that
can help the cardiology community better treat their diverse
patient populations.” The report notes that credo’s efforts
also extend to research and efforts to improve registry data
collection around race and ethnicity (11). By developing and
disseminating evidence-based educational tools, credo seeks
to help clinicians better serve all of their patients, regardless
of race, ethnicity, gender, primary language, or other factors
that may inﬂuence care.We are also delighted to hear that research into invasive
cardiology disparities is being addressed by our sister orga-
nization, the Society for Cardiovascular Angiography and
Interventions, which recently announced the initiation of the
Health Disparities Research Consortium (http://www.
disparitiesresearch.org), with the expressed mission to
“improve the quality of life and health outcomes of women
and minority patients through education, research and
partnership” by speciﬁcally enrolling understudied pop-
ulations into clinical trials. We invite you, as ACC members,
to join us in each of these efforts. Your comments and
feedback suggestions for initiatives in your practice or your
community are also encouraged.
This is indeed “our” problem, after all.
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